Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Genvynn Biologics Private Limited, is an unlisted private company incorporated on 21 July, 2020. It is classified as a private limited company and is located in Faridabad, Haryana. It's authorized share capital is INR 16.00 lac and the total paid-up capital is INR 16.00 lac.
The current status of Genvynn Biologics Private Limited is - Active.
Read more
Buy Dashboard using Credits
** All rupee values in INR crores. Based on March 2024 numbers.
8.9%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
Choose number of credits to buy
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
India
(1)
| State | Type | Address |
|---|---|---|
| Haryana | Registered Office | B-79, BASEMENT ASHOKA ENCLAVE-II, SECTOR 37, FARIDABAD HARYANA Faridabad Haryana - 121003 |
Locations on Map
Filter (4)
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Satish Babu Guntupalli | 06795927 | 5 years |
| Director | Narahari Prasad Reddy Ponnapu Reddy | 08803262 | 5 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| THEERTHA TECHNOLOGIES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
| AEGLE BIOPHARMA PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Karnataka |
| THEERTHA BIOPHARMA PRIVATE LIMITED |
Active
|
5.0 L | 1 | Karnataka |
| INNONIQ TECHNOLOGIES PRIVATE LIMITED |
Active
|
5.0 L | 1 | Karnataka |
Severe Risk
Moderate Risk
Low Risk
Read more
The incorporation date of GENVYNN BIOLOGICS PRIVATE LIMITED is 21 July, 2020
The authorized share capital of GENVYNN BIOLOGICS PRIVATE LIMITED is INR ₹ 16.0 L.
The paid-up capital of GENVYNN BIOLOGICS PRIVATE LIMITED is INR ₹ 16.0 L.
The registered address of GENVYNN BIOLOGICS PRIVATE LIMITED is B-79, BASEMENT ASHOKA ENCLAVE-II, SECTOR 37, FARIDABAD HARYANA Faridabad Haryana - 121003
The CIN number of GENVYNN BIOLOGICS PRIVATE LIMITED is U24290HR2020PTC087733.
